Additional information
| Indication | Kidney cancer |
|---|---|
| Strength | Pazopanib (400mg) |
| Manufacturer | Glaxo SmithKline Pharmaceuticals Ltd |
| Pharmaceutical Form | Tablet |
| Pack Size | 30 Tablet, 60 Tablet, 90 Tablet, 120 Tablet, 180 Tablet |
Votrient 400 mg
$180.00 – $1,007.00
Votrient 400 mg (Pazopanib) Tablet is a protein kinase inhibitor to handle kidney cancer and soft tissue sarcoma.
Reviews
There are no reviews yet.